Identifying and predicting fast versus slow Parkinson's disease motor progressors using clinical and digital data.

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

BackgroundDigital health technologies offer high-frequency, objective measures for Parkinson's disease (PD) yet individual stratification is lacking. This study aimed to identify and predict fast versus slow PD motor progressors by integrating longitudinal clinical evaluation with smartphone motor testing.MethodsIn this 96-week subgroup analysis of participants in the Exenatide-PD3 trial, motor progression was measured using Movement Disorder Society-Unified Parkinson's Disease Rating Scale Part III OFF scores and smartphone testing (baseline, weeks 24, 48, 72, 96). Fast versus slow progressors were identified using data-driven subtyping; linear mixed-effects models assessed longitudinal OFF scores. Baseline clinical and digital features (in-clinic and at-home) were used to predict 96-week motor progression. Model performance was quantified by the area under the receiver operating curve (AUC).ResultsData-driven clustering identified 26.5% (26/98) as fast progressors, with higher baseline OFF scores (+18.16, 95% CI 13.70 to 22.62; adjusted p96% support future in-clinic use) and predictive value in a deployment scenario (AUC 0.80, 95% CI 0.79 to 0.82).ConclusionData-driven clustering identified one in four early-to-mid stage PD patients as fast motor progressors. Integrating smartphone-derived features with clinical scores improved baseline motor prediction. High user acceptability supports this approach for individual-level PD stratification, addressing heterogeneity in motor progression that may obscure treatment trial effects.

Related topics